Quick Takeaways
- Daniel M. Junius has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,968,554.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Daniel M. Junius
- Location
- Waltham, MA
- Summary
- The estimated net worth of Daniel M. Junius is at least $1,968,554 dollars as of 14 May 2025. Daniel M. Junius is the Director of IDEXX LABORATORIES INC /DE and owns shares of IDEXX LABORATORIES INC /DE (IDXX) stock worth about $1.67M. Daniel M. Junius is the Director of GLYCOMIMETICS INC and owns shares of CRESCENT BIOPHARMA, INC. (CBIO) stock worth about $295.4K.
- Signature
- /s/ Lily J. Lu, Attorney-in-Fact for Daniel M. Junius
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Daniel M. Junius and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: IDEXX LABORATORIES INC /DE ($1,673,177).
- Past-year value change for that position: -$1,358,697.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Daniel M. Junius
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| IDXX | IDEXX LABORATORIES INC /DE | Director | $1,673,177 | -$1,358,697 | -45% | 13 May 2025 |
| CBIO | GLYCOMIMETICS INC | Director | $295,377 | 01 May 2024 |
Insider Transactions Reported by Daniel M. Junius:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.